Author Correction: Lead compounds for the development of SARS-CoV-2 3CL protease inhibitors
Título
Author Correction: Lead compounds for the development of SARS-CoV-2 3CL protease inhibitors
Autor
Sho Iketani, Farhad Forouhar, Hengrui Liu, Seo Jung Hong, Fang-Yu Lin, Manoj S. Nair, Arie Zask, Yaoxing Huang, Li Xing, Brent R. Stockwell, Alejandro Chavez, David D. Ho
Descripción
A Correction to this paper has been published: https://doi.org/10.1038/s41467-021-23082-3
Fecha
2021
Identificador
10.1038/s41467-021-23082-3
Fuente
Epidemiology and Health
Editor
Korean Society of Epidemiology
Cobertura
Science
Archivos
Colección
Citación
Sho Iketani, Farhad Forouhar, Hengrui Liu, Seo Jung Hong, Fang-Yu Lin, Manoj S. Nair, Arie Zask, Yaoxing Huang, Li Xing, Brent R. Stockwell, Alejandro Chavez, David D. Ho, “Author Correction: Lead compounds for the development of SARS-CoV-2 3CL protease inhibitors,” SOCICT Open, consulta 21 de abril de 2026, https://socictopen.socict.org/items/show/8926.
Position: 11177 (24 views)